Valuation: INSTITUT

Market Cap 4.4B 52.52M 46.67M 43.55M 39.7M 74.87M 5.05B 75.57M 527M 204M 2.58B 197M 193M 8.28B P/E 2024
25.7x
P/E 2025 46.2x
Enterprise Value 4.64B 55.32M 49.15M 45.88M 41.81M 78.86M 5.32B 79.59M 555M 215M 2.72B 208M 203M 8.73B EV / Sales 2024
3.02x
EV / Sales 2025 2.7x
Free-Float
17.07%
Yield 2024 *
-
Yield 2025 2.02%
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 68 2010-08-22
Director/Board Member 47 2014-01-08
Director/Board Member 45 2010-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%-3.00%+11.58%+24.85% 111B
+0.78%-2.05%-0.66%+74.89% 92.38B
+0.46%-0.54%+145.20%+833.67% 59.15B
-0.38%-5.45%-7.47%+54.41% 27.66B
+0.97%-1.27%+30.11%+92.79% 25.75B
+1.28%-0.37%+11.39%+53.88% 25.02B
-0.67%-0.58%-16.34%-7.26% 20.99B
+1.83%-0.42%+27.40%+309.14% 20.82B
+1.30%-2.86%-4.06%+34.25% 16.87B
Average +0.78%-1.83%+21.90%+163.40% 44.36B
Weighted average by Cap. +0.89%-2.05%+27.10%+178.05%

Financials

2024 2025
Net sales 1.52B 18.16M 16.13M 15.06M 13.72M 25.88M 1.75B 26.12M 182M 70.61M 892M 68.17M 66.69M 2.86B 1.72B 20.48M 18.2M 16.98M 15.48M 29.19M 1.97B 29.47M 206M 79.64M 1.01B 76.89M 75.22M 3.23B
Net income 215M 2.56M 2.28M 2.13M 1.94M 3.66M 247M 3.69M 25.74M 9.97M 126M 9.63M 9.42M 404M 96.95M 1.16M 1.03M 959K 874K 1.65M 111M 1.66M 11.61M 4.5M 56.86M 4.34M 4.25M 182M
Net Debt 199M 2.38M 2.11M 1.97M 1.8M 3.39M 229M 3.42M 23.86M 9.24M 117M 8.92M 8.73M 375M 234M 2.8M 2.49M 2.32M 2.12M 3.99M 269M 4.03M 28.08M 10.88M 138M 10.51M 10.28M 441M
Logo INSTITUT
Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.
Employees
-